2025 Updates in Hematology and Oncology, Houston

Houston, TX US
July 26, 2025 to July 27, 2025

The CME-accredited 2025 Updates in Hematology and Oncology Conference – Houston is designed to enhance cancer care by equipping healthcare professionals with the latest knowledge and advancements in the field. Through case-based presentations, expert-led didactic lectures, and interactive Q&A sessions, this conference will deliver a comprehensive review of recent breakthroughs in hematology and oncology. Our esteemed faculty will translate emerging data into practical insights, highlighting how new evidence may reshape current standards of care. Tailored for physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other cancer care professionals, the program emphasizes a multidisciplinary, patient-centered approach to integrating cutting-edge science into everyday practice.

Target Audience

  • Medical oncologists
  • Radiation oncologists
  • Surgical oncologists
  • Oncology residents/fellows
  • Oncology NPs/PAs
  • Oncology pharmacists
  • Oncology nurses

Organizing Committee: 

Course Director:

  • Binay Shah, MD, MHA - Binaytara

Co-Chairs:

  • Julie Nangia, MD - Baylor College of Medicine
  • Shilpan Shah, MD - Houston Methodist

Learning Objectives

At the conclusion of this activity, participants will be able to:

  • Discuss new and emerging treatment strategies for patients with hematologic malignancies and solid tumors.
  • Evaluate the clinical evidence supporting recent advancements in cancer diagnostics and therapeutics.
  • Identify indications, contraindications, and common adverse effects of current and novel cancer therapies.
  • Implement best practices for managing treatment-related toxicities and improving patient quality of life.
  • Integrate multidisciplinary approaches to optimize individualized, evidence-based cancer care.
Course summary
Available credit: 
  • 10.50 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.50 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 10.50 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 10.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 10.50 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 10.50 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 10.50 Contact Hours.
Course opens: 
02/07/2025
Course expires: 
10/31/2025
Event starts: 
07/26/2025 - 8:00am PDT
Event ends: 
07/27/2025 - 12:15pm PDT
Cost:
$350.00

DAY 1 - SATURDAY, JULY 26, 2025

All times below are listed in Central Daylight Time (CDT)

07:00 AM – 08:00 AM  Registration, Breakfast, and Exhibits


08:00 AM – 08:05 AM  Welcome


08:05 AM – 09:35 AM  Session 1 - Hematologic Malignancies 

Session Chair: Shilpan Shah, MD

08:05 AM – 08:35 AM  MDS/Leukemias - Nitin Jain, MD

08:35 AM – 09:05 AM  Multiple Myeloma - Martha Pritchett Mims, MD, PhD

09:05 AM – 09:35 AM  Lymphoma & CLL 


09:35 AM – 09:45 AM  Break and Exhibits


09:45 AM – 11:05 AM  Session 2 - General Oncology 

Session Chair: Tracilyn Rachelle Hall, MD

09:45 AM – 10:15 AM  Sarcoma - Neeta Somaiah, MD

10:05 AM – 10:45 AM  Cutaneous Malignancies 

10:45 AM – 11:05 AM  Gynecologic - Tracilyn Rachelle Hall, MD


11:05 AM – 11:55 AM  Session 3 - Tumor- Board Style Case-based Discussion: Challenging Cases


11:55 AM – 12:15 PM  Access to Cancer Care in LMIC - Binay Shah, MD, MHA 


12:15 PM – 01:15 PM  Lunch & Exhibits


01:15 PM – 02:45 PM  Session 4 - Genitourinary Cancer

Session Chair: Bilal A Siddiqui, MD

01:15 PM – 01:45 PM  Prostate Cancer - Bilal A Siddiqui, MD

01:45 PM – 02:15 PM  Bladder Cancer 

02:15 PM – 02:45 PM  Kidney Cancer - Patrick Prath, MD


02:45 PM – 03:15 PM  Break and Exhibits 


03:15 PM – 04:45 PM  Session 5 - Gastrointestinal Cancer

Session Chair:Shalini U Makawita, MD, MSc

03:15 PM – 03:45 PM  Upper GI Cancer 

03:45 PM – 04:15 PM  Hepatobiliary and Pancreatic Malignancies - Sunyoung S. Lee, MD, PhD

04:15 PM – 04:45 PM  Colorectal Cancer - Shalini U Makawita, MD, MSc


04:45 PM – 05:30 PM  Reception and Networking

 

DAY 2 - SUNDAY, JULY 27, 2025

07:00 AM – 08:00 AM  Registration, Breakfast, and Exhibits 


08:00 AM – 09:30 AM  Session 6 - Breast Cancer

Session Chair: Michelina Cairo, MD

08:00 AM – 08:30 AM  Hormone Receptor Positive Breast Cancer - Darya Kizub, MD

08:30 AM – 09:00 AM  Triple Negative Breast Cancer - Akshjot Puri, MD

09:00 AM – 09:30 AM  HER2-Positive Breast Cancer - Polly Niravath MD


09:30 AM – 10:15 AM  Session 7 - Tumor-Board Style Discussion: Challenging Cases


10:15 AM – 10:30 AM  Break and Exhibits


10:30 AM – 12:00 PM  Session 8 - Thoracic Oncology

Session Chair: Jun Zhang, MD

10:30 AM – 11:00 AM  Early-Stage Non-Small Cell Lung Cancer - Jian Guan, MD, PhD

11:00 AM – 11:30 AM  Metastatic Non-Small Cell Lung Cancer - Jianjun Zhang, MD, PhD

11:30 AM – 12:00 PM  Small Cell Lung Cancer - Meera Patel, MD, MHS


12:00 PM  Adjourn

The Westin Houston Medical Center/Museum District
1709 Dryden Rd
Houston, TX 77030
United States

A limited number of rooms are reserved at the venue for participants and exhibitors of this conference. Please book your hotel room at the link below by June 24, 2025 to receive the group rate. 

Book your group rate for Updated in Hematology Oncology, Houston

IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

All conflict of interest has been identified and mitigated for individuals in control of contents.

PLANNING COMMITTEE DISCLOSURE STATEMENT:

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

 

Session Chair(s)

Michelina Cairo, MD

has a financial relationship (Professional Services) with Novartis;.
has a financial relationship (Professional Services) with Gilead Sciences;.
has a financial relationship (Professional Services) with Astra Zeneca/Daiichi Sankyo;.
has a financial relationship (Professional Services) with Pfizer;.
has a financial relationship (Professional Services) with Biotheranostics;.
has a financial relationship (Professional Services) with Seagen;.
Speaker/Topic Presenter(s)

Akshjot Puri, MD

has a financial relationship (Professional Services) with Novartis;.

Neeta Somaiah, MD

has a financial relationship (Grant Or Contract) with Bayer;.
has a financial relationship (Grant Or Contract) with Deciphera;.
has a financial relationship (Grant Or Contract) with IDRX;.
has a financial relationship (Grant Or Contract) with Cogent;.
has a financial relationship (Grant Or Contract) with Boehringer Ingelheim;.
has a financial relationship (Grant Or Contract) with Ascentage;.
has a financial relationship (Grant Or Contract) with Astrazeneca;.
has a financial relationship (Independent contractor) with Deciphera;.
has a financial relationship (Independent contractor) with Ipsen;.

Available Credit

  • 10.50 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.50 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 10.50 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 10.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 10.50 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 10.50 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 10.50 Contact Hours.

If you are interested in exhibiting at this meeting or purchasing a badge with your company at our discounted rate for exhibitors, please visit our exhibit page here - https://www.sponsorships.binaytara.org/HoustonHemeOnc

 

 

Price

Cost:
$350.00
Please login or register to take this course.

POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE: 

All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place. 

The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference.  The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees. 

If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.

Violating this policy will result in a fine equivalent to a general display fee for that conference. 

 

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 
  • If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
  • No refunds will be issued if registration is canceled after that date.  

No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.